Literature DB >> 2505304

Fluvoxamine, imipramine, and placebo in the treatment of depressed outpatients: effects on depression.

R B Lydiard, L K Laird, W A Morton, T E Steele, C Kellner, M T Laraia, J C Ballenger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2505304

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  10 in total

1.  How can research ethics committees protect patients better?

Authors:  Silvio Garattini; Vittorio Bertele; Luca Li Bassi
Journal:  BMJ       Date:  2003-05-31

2.  A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.

Authors:  Walter W van den Broek; Tom K Birkenhäger; Paul G H Mulder; Jan A Bruijn; Peter Moleman
Journal:  Psychopharmacology (Berl)       Date:  2004-10       Impact factor: 4.530

Review 3.  Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.

Authors:  Ewgeni Jakubovski; Anjali L Varigonda; Nicholas Freemantle; Matthew J Taylor; Michael H Bloch
Journal:  Am J Psychiatry       Date:  2015-11-10       Impact factor: 18.112

4.  Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials.

Authors:  Bret R Rutherford; Joel R Sneed; Steven P Roose
Journal:  Psychother Psychosom       Date:  2009-03-24       Impact factor: 17.659

5.  Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.

Authors:  I M Anderson; B M Tomenson
Journal:  BMJ       Date:  1995-06-03

Review 6.  Fluvoxamine versus other anti-depressive agents for depression.

Authors:  Ichiro M Omori; Norio Watanabe; Atsuo Nakagawa; Andrea Cipriani; Corrado Barbui; Hugh McGuire; Rachel Churchill; Toshi A Furukawa
Journal:  Cochrane Database Syst Rev       Date:  2010-03-17

Review 7.  Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis.

Authors:  Barbara Nussbaumer; Laura C Morgan; Ursula Reichenpfader; Amy Greenblatt; Richard A Hansen; Megan Van Noord; Linda Lux; Bradley N Gaynes; Gerald Gartlehner
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

8.  Less is more in antidepressant clinical trials: a meta-analysis of the effect of visit frequency on treatment response and dropout.

Authors:  Bret R Rutherford; Timothy M Cooper; Amanda Persaud; Patrick J Brown; Joel R Sneed; Steven P Roose
Journal:  J Clin Psychiatry       Date:  2013-07       Impact factor: 4.384

Review 9.  The relationship between borderline personality disorder and bipolar disorder.

Authors:  Mark Zimmerman; Theresa A Morgan
Journal:  Dialogues Clin Neurosci       Date:  2013-06       Impact factor: 5.986

Review 10.  Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis.

Authors:  Janus Christian Jakobsen; Kiran Kumar Katakam; Anne Schou; Signe Gade Hellmuth; Sandra Elkjær Stallknecht; Katja Leth-Møller; Maria Iversen; Marianne Bjørnø Banke; Iggiannguaq Juhl Petersen; Sarah Louise Klingenberg; Jesper Krogh; Sebastian Elgaard Ebert; Anne Timm; Jane Lindschou; Christian Gluud
Journal:  BMC Psychiatry       Date:  2017-02-08       Impact factor: 3.630
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.